Validation of biocides against duck hepatitis B virus as a surrogate virus for human hepatitis B virus

Journal of Hospital Infection

Volumn 64, Issue 4, 2006, Pages 358-365

  Sauerbrei, A ^a   Schacke, M ^a   Gluck B ^a   Egerer, R ^a   Wutzler, P ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

D2 cell line; Duck hepatitis B virus; Formaldehyde; Immunofluorescent antigen staining; Peracetic acid; Povidone iodine; Quantitative PCR

Indexed keywords

BIOCIDE; FORMALDEHYDE; PERACETIC ACID; POVIDONE IODINE;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DUCK; GENETIC TRANSFECTION; HEPADNAVIRUS; HEPATITIS B VIRUS; HEPATOMA CELL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; NONHUMAN; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RELIABILITY; SENSITIVITY ANALYSIS; SUSPENSION; VALIDATION PROCESS; VIRUS GENOME; VIRUS INACTIVATION;

ANIMALS; CELLS, CULTURED; DISINFECTANTS; DUCKS; FLUORESCENT ANTIBODY TECHNIQUE; FORMALDEHYDE; HEPATITIS B VIRUS; HEPATITIS B VIRUS, DUCK; HUMANS; INFECTION CONTROL; MICROBIAL SENSITIVITY TESTS; MODELS, ANIMAL; ORGANOMETALLIC COMPOUNDS; PEPTIDES; PERACETIC ACID; POVIDONE-IODINE;

EID: 33750526704     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhin.2006.04.013     Document Type: Article

References (32)

1. Sattar S.A., Treto J., Springthorpe V.S., and Giulivi A. Preventing the spread of hepatitis B and C viruses: where are germicides relevant?. Am J Infect Control 29 (2001) 187-197
2. Thraenhart O., and Jursch C. Measures for disinfection and control of viral hepatitis. In: Block S.S. (Ed). Disinfection, sterilisation, and preservation. 5th edn (2001), Lea & Febiger, Philadelphia 585-615
3. Thraenhart O., Kuwert E.K., Scheiermann N., et al. Comparison of the morphological alteration and disintegration test (MADT) and the chimpanzee infectivity test for determination of hepatitis B virucidal activity of chemical disinfectants. Zentralbl Bacteriol Mikrobiol Hyg [B] 176 (1982) 472-484
4. Howard C.R., Dixon J., Young P., van Eerd P., and Schellekens H. Chemical inactivation of hepatitis B virus: the effect of disinfectants on virus-associated DNA polymerase activity, morphology and infectivity. J Virol Methods 7 (1983) 135-148
5. Hilfenhaus J., Groner A., Nowak T., and Weimer T. Analysis of human plasma products: polymerase chain reaction does not discriminate between live and inactivated viruses. Transfusion 37 (1997) 935-940
6. Jursch C.A., Gerlich W.H., Glebe D., Schaefer S., Marie O., and Thraenhart O. Molecular approaches to validate disinfectants against human hepatitis B virus. Med Microbiol Immunol 190 (2002) 189-197
7. Tuttleman J.S., Pourcel C., and Summers J. Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells. Cell 47 (1986) 451-460
8. Marion P.L., Cullen J.M., Azcarraga R.R., Van Davelaar M.J., and Robinson W.S. Experimental transmission of duck hepatitis B virus to Pekin ducks and to domestic geese. Hepatology 7 (1967) 724-731
9. Murray S.M., Freiman J.S., Vickery K., Lim D., Cossart Y.E., and Whiteley R.K. Duck hepatitis B virus: a model to assess efficacy of disinfectants against hepadnavirus infectivity. Epidemiol Infect 106 (1991) 435-443
10. Prince D.L., Prince N., Thraenhart O., Muchmore E., Bonder E., and Pugh J. Methodological approaches to disinfection of human hepatitis B virus. J Clin Microbiol 31 (1993) 3296-3304
11. Chaufour X., Deaf A.K., Vickery K., et al. Evaluation of disinfection and sterilization of reusable angioscopes with the duck hepatitis B model. J Vasc Surg 30 (1999) 277-282
12. US Environmental Protection Agency. Protocol for testing the efficacy of disinfectants used to inactivate duck hepatitis B virus and to support corresponding label claims. 2000.
13. European Committee for Standardisation. Chemical disinfectants and antiseptics - virucidal quantitative suspension test for chemical disinfectants and antiseptics used in human medicine. Test method and requirements (phase 2, step 1). prEN 14476. 2002.
14. Sauerbrei A., Schacke M., Schultz U., et al. Alternative methods for validation of cell culture infection with duck hepatitis B virus. J Virol Methods 129 (2005) 178-185
15. Condreay L.D., Aldrich C.E., Coates L., Mason W.S., and Wu T.T. Efficient duck hepatitis B virus production by an avian liver tumor cell line. J Virol 64 (1990) 3249-3258
16. Mücke H. Zur Bestimmung und zum Spurennachweis von Peressigsäure in Gegenwart von Wasserstoffperoxid für die Praxis der Kaltsterilisation und Desinfektion. Z Med Labortech 14 (1973) 319-323
17. Leitlinie der Deutschen Vereinigung zur Bekämpfung der Viruskrankheiten e.V. und des Robert Koch-Instituts zur Prüfung von chemischen Desinfektionsmitteln auf Wirksamkeit gegen Viren in der Humanmedizin. Fassung vom 15. Juni 2005. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 48 (2005) 1420-1426
18. Sauerbrei A., Sehr K., Brandstädt A., Heim A., Reimer K., and Wutzler P. Sensitivity of human adenoviruses to different groups of chemical biocides. J Hosp Infect 57 (2004) 59-66
19. Wutzler P., Sauerbrei A., Klöcking R., Brögmann B., and Reimer K. Virucidal activity and cytotoxicity of the liposomal formulation of povidone-iodine. Antiviral Res 54 (2002) 89-97
20. Wutzler P., and Sauerbrei A. Virucidal activity of the new disinfectant monopercitric acid. Lett Appl Microbiol 39 (2004) 194-198
21. Steinmann J. Surrogate viruses for testing virucidal efficacy of chemical disinfectants. J Hosp Infect 56 (2004) S49-S54
22. Block S.S. Peroxygen compounds. In: Block S.S. (Ed). Disinfection, sterilisation, and preservation using SyBr green. 4th edn (1991), Lippincott Williams & Wilkins, Philadelphia 185-204
23. Vickery K., Deva A.K., Zou J., Kumaradeva P., Bissett L., and Cossart Y.E. Inactivation of duck hepatitis B virus by a hydrogen peroxide gas plasma sterilization system: laboratory and 'in use' testing. J Hosp Infect 41 (1999) 317-322
24. Tsiquaye K.N., and Barnard J. Chemical disinfection of duck hepatitis B virus: a model for inactivation of infectivity of hepatitis B virus. J Antimicrob Chemother 32 (1993) 313-323
25. Deva A.K., Vickery K., Zou J., West R.H., Harris J.P., and Cossart Y.E. Establishment of an in-use testing method for evaluating disinfection of surgical instruments using the duck hepatitis B model. J Hosp Infect 33 (1996) 119-130
26. Gerlich W. Hepatitis B surface proteins. J Hepatol 13 Suppl. 4 (1991) S90-S92
27. Wang C.J., Giambrone J.J., and Smith B.F. Development of viral disinfectant assays for duck hepatitis B virus using cell culture/PCR. J Virol Methods 106 (2002) 39-50
28. Wang C.J., Giambrone J.J., and Smith B.F. Comparison of cell culture systems for duck hepatitis B virus using SyBr grenn quantitative PCR. J Virol Methods 106 (2002) 175-184
29. Maillard J.Y. Virucidal activity of biocides. In: Fraise A.P., Lambert P.A., and Maillard J.Y. (Eds). Rusell, Hugo & Ayliffe's principles and practice of disinfection, preservation & sterilization. 4th edn (2004), Blackwell, Oxford 272-323
30. Ojeh C.K., Cusack T.M., and Yolken R.H. Evaluation of the effects of disinfectants on rotavirus RNA and infectivity by the polymerase chain reaction and cell-culture methods. Mol Cell Probes 9 (1995) 341-346
31. Sauerbrei A., Sehr K., Eichhorn U., Reimer K., and Wutzler P. Inactivation of adenovirus genome by different groups of disinfectants. J Hosp Infect 57 (2004) 67-72
32. Robert K.-I. Liste der vom Robert-Koch-Institut geprüften und anerkannten Desinfektionsmittel und -verfahren. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 46 (2003) 72-95